Depression Prevention Program for Adolescents

NCT ID: NCT00183417

Last Updated: 2012-04-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

350 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-09-30

Study Completion Date

2009-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will compare the effectiveness of two programs designed to prevent depression in adolescents.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Major depression is one of the most common psychiatric disorders in adolescents. In many cases, the condition is recurrent and can result in serious psychological impairment. A high number of depressed adolescents never receive treatment; therefore, it is crucial to develop prevention programs for this disorder that are effective and can be easily disseminated. This study will evaluate and compare the effectiveness of cognitive behavior therapy (CBT) and supportive/expressive (S/E) therapy in preventing depressive symptoms in adolescents.

This study will last 2 years. Participants will be randomly assigned to receive six sessions of CBT, S/E therapy, or standard depression education over 2 years. The CBT intervention will focus on reducing negative thoughts and increasing engagement in pleasant activities. S/E therapy is designed to allow adolescents to express their negative emotions and talk about recent stressful events in a supportive environment of their peers. Surveys and psychiatric interviews will be completed by all participants and their parents at the beginning and the end of the study. The surveys and interviews will assess depressive symptoms.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Participants will receive cognitive behavioral therapy

Group Type EXPERIMENTAL

Cognitive behavior therapy (CBT)

Intervention Type BEHAVIORAL

Participants will complete worksheets and group discussion on how to increase positive mood and activity.

2

Participants will receive supportive/expressive therapy

Group Type ACTIVE_COMPARATOR

Supportive/expressive (S/E) therapy

Intervention Type BEHAVIORAL

Participants will be encouraged to express feelings and emotions without advice giving.

3

Participants will receive bibliotherapy

Group Type ACTIVE_COMPARATOR

Bibliotherapy

Intervention Type BEHAVIORAL

Participants will be given a book on how to increase their mood.

4

Participants in the control condition will receive no treatment

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cognitive behavior therapy (CBT)

Participants will complete worksheets and group discussion on how to increase positive mood and activity.

Intervention Type BEHAVIORAL

Supportive/expressive (S/E) therapy

Participants will be encouraged to express feelings and emotions without advice giving.

Intervention Type BEHAVIORAL

Bibliotherapy

Participants will be given a book on how to increase their mood.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Beck Depression Inventory score higher than 10
* Parent or guardian willing to provide informed consent

Exclusion Criteria

* Diagnosis of depression
Minimum Eligible Age

14 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Mental Health (NIMH)

NIH

Sponsor Role collaborator

University of Texas at Austin

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eric M. Stice, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Texas at Austin

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Texas at Austin

Austin, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Gau JM, Stice E, Rohde P, Seeley JR. Negative life events and substance use moderate cognitive behavioral adolescent depression prevention intervention. Cogn Behav Ther. 2012;41(3):241-50. doi: 10.1080/16506073.2011.649781. Epub 2012 Mar 13.

Reference Type DERIVED
PMID: 22414236 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01MH067183

Identifier Type: NIH

Identifier Source: secondary_id

View Link

DSIR 84-CTP

Identifier Type: -

Identifier Source: secondary_id

R01MH067183

Identifier Type: NIH

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Treatment of Post-TBI Depression
NCT00211835 COMPLETED NA